Drucken
Artikel, Notizen und Markierungen werden geladen... Bitte um etwas Geduld.

Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)

Art. 44 Import of individual batches of immunological medicinal products that are authorised or not subject to authorisation or of blood and blood products

1 Any per­son who im­ports the fol­low­ing medi­cin­al products that are au­thor­ised or not sub­ject to au­thor­isa­tion or blood and blood products in­to Switzer­land re­quires a li­cence for each ship­ment:

a.
im­mun­o­lo­gic­al medi­cin­al products;
b.
blood and blood products.

2 A li­cence is not re­quired for the im­port of in­di­vidu­al batches of:

a.
al­ler­gens;
b.
blood that is au­thor­ised or not sub­ject to au­thor­isa­tion and blood products of this kind if these medi­cin­al products:
1.
are im­por­ted in med­ic­al emer­gen­cies or for auto­log­ous trans­fu­sion,
2.
are not in­ten­ded for use in hu­mans, or
3.
have an of­fi­cial batch re­lease from one of the con­trol au­thor­it­ies be­long­ing to the Of­fi­cial Con­trol Au­thor­ity Batch Re­lease Net­work (OCABR Net­work);
c.
im­mun­o­lo­gic­al medi­cin­al products that are au­thor­ised or not sub­ject to au­thor­isa­tion provided an of­fi­cial batch re­lease from one of the con­trol au­thor­it­ies be­long­ing to the OCABR Net­work is avail­able for the batch to be im­por­ted.

3 In the in­terest of pro­tect­ing health, Swiss­med­ic may im­pose tem­por­ary or per­man­ent man­dat­ory li­cens­ing on the im­port of in­di­vidu­al batches of im­mun­o­lo­gic­al medi­cin­al products or of blood and blood products that are au­thor­ised or not sub­ject to au­thor­isa­tion even if an of­fi­cial batch re­lease as de­scribed in para­graph 2 let­ter b num­ber 3 is avail­able.